COVID-19 and ECCMID

In light of the current outbreak of COVID-19, ESCMID has been fielding questions regarding ECCMID.

As of now, the ESCMID Executive Committee and ECCMID Programme Directors have decided to continue preparations for the congress, and have no immediate plans to cancel or postpone the event. 

More detailed information can be found on the ECCMID Website, as well as an updated cancellation policy.

Up-to date reports on the evolving COVID-19 outbreak can be found on the EITaF Outbreak News page.

› Read more

ESCMID Course Announcement:
Antimicrobial susceptibility with EUCAST criteria and methods

19^th ESCMID Summer School – Registrations now open

Registrations are now open for the 19^th ESCMID Summer School, to be held in Carcavelos, Portugal from 27 June – 4 July 2020.

Visit the course website to view the programme, as well as other information about the course. Be quick, this course is bound to sell out soon!

› Read more

European Examination in Medical Microbiology

UEMS Section of Medical Microbiology, in partnership with ESCMID, is developing an exit examination which once developed will lead to a European Specialist Diploma in Medical Microbiology.
The examination will examine knowledge based on the UEMS Section of Medical Microbiology core curriculum and current European best practice guidelines.

The PILOT examination will take place on Friday 17^th April 2020 in Paris from 3-6 pm. Registration is from 2-3 pm.
This exam is offered free of charge, and -as a pilot- will not lead to the award of a Diploma.

Please see the UEMS section Medical Microbiology website for further information including

• the criteria for entry to the exam and application form 
• the application process and terms and conditions

Completed applications and supporting documents should be forwarded to uemsmmsection@hotmail.com

› Read more

CMI highlight: First Atypical case of 2019 novel coronavirus in Yan'an, China

W. Hao et al. present the case of the first atypical case of novel coronavirus in China. A 60-year-old man with a travel history to Wuhan, China, where the 2019 novel coronavirus (2019-nCoV) was spreading, presented to the emergency department with a 5-day history of unexplained fatigue. The patient's chest CT scan demonstrated a patchy high-density shadow in both lungs; however, the patient’s oropharyngeal swab was negative for the 2019 Novel Coronavirus on the real-time reverse transcription polymerase chain reaction assay.

After 5 days of treatment, a chest CT scan was performed again to show patchy consolidation, and another sample of the patient's oropharyngeal swab was taken again for the 2019-nCoV nucleic acid test, which showed a positive result. This case was special because the patient had no respiratory symptoms like fever or cough, and the diagnosis required several repeated nucleic acid tests. The authors conclude that the rapid progression of chest imaging in the short term has critical diagnostic value for patients with negative 2019-nCoV nucleic acid tests.

› Read more